Life Science News

Latest updates from the biotech and pharma world

BioWorld 2026-02-25

In the clinic for Feb. 25, 2026

BioWorld 2026-02-25

Other news to note for Feb. 25, 2026

BioWorld 2026-02-25

Regulatory actions for Feb. 25, 2026

BioWorld 2026-02-25

Covant Therapeutics patents FcRn antagonists

BioWorld 2026-02-25

Blossomhill Therapeutics reports new EGFR inhibitors

BioWorld 2026-02-25

PARG inhibitors disclosed in Avelos Therapeutics patent

BioWorld 2026-02-25

Shanghai Meiyue Biotech patents divulge c-KIT inhibitors

BioWorld 2026-02-25

Waverley Pharma synthesizes PARP-1 inhibitors

BioWorld 2026-02-24

Appointments and advancements for Feb. 24, 2026

BioWorld 2026-02-24

Financings for Feb. 24, 2026

BioWorld 2026-02-24

In the clinic for Feb. 24, 2026

BioWorld 2026-02-24

Regulatory actions for Feb. 24, 2026

BioWorld 2026-02-24

Astellas and Vir in $1.3B deal for CD3 T-cell engager

BioWorld 2026-02-24

Innovacell’s $91M Tokyo IPO to fund incontinence cell therapies

BioWorld 2026-02-24

Other news to note for Feb. 24, 2026

BioWorld 2026-02-24

Harbour Biomed spins out newco in $1.2B CTLA-4 deal

BioWorld 2026-02-24

Gilead-Genhouse's $1.5B+ deal boosts synthetic lethality push

BioWorld 2026-02-24

Appointments and advancements for Feb. 24, 2026

BioWorld 2026-02-24

Financings for Feb. 24, 2026

BioWorld 2026-02-24

In the clinic for Feb. 24, 2026

3 / 36